2014-02-24 09:52:01 - Global Deep Brain Stimulator Market 2012-2016 - a new market research report on companiesandmarkets.com
The Global Deep Brain Stimulator market is to grow at a CAGR of 16.99 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapidly increasing awareness about deep brain stimulation devices in the US. The Global Deep Brain Stimulator market has also been witnessing the emergence of less invasive and non-invasive treatments. However, the high cost of deep brain stimulation treatment could pose a challenge to the growth of this market.
There is a general perception that DBS treatments are risky since they involve surgery to implant electrodes in the brain. Hence, less invasive and non-invasive DBS treatments are gaining greater acceptance from doctors and surgeons in the Healthcare industry. New lines of
research in the R and D sector are enabling surgeons and healthcare specialists to carry out more selective stimulation. For instance, selective stimulation is used with respect to the innervation of the urinary bladder at peripheral sites (such as pudendal nerve stimulation) with the use of less invasive devices such as Bion and other implantable devices. Thus, the adoption of alternative treatments that are less invasive is seen to be an emerging trend during the forecast period.
One of the key drivers in this market is that DBS therapy is considered to be the standard form of care for many diseases and conditions such as epilepsy, depression, stroke, anxiety disorders, and Parkinson’s disease. Hence, this market is expected to grow at a rapid pace and achieve a similar market size to the Global Cardiac Devices market.
One of the major challenges in the market is the high cost of deep brain stimulation treatments and therapies. The high cost has rendered deep brain stimulation treatments and therapies unaffordable for patients in developing nations.
The key vendors dominating this space are Boston Scientific Corp., Medtronic Inc., and St. Jude Medical Inc. The other vendors mentioned in the report are Advanced Neuromodulation Systems Inc., BioControl Medical Ltd., Carl Zeiss Inc., cerboMed GmbH, Codman & Shurtleff Inc., Cyberonics Inc., DePuy Inc., EndoStim Inc., EnteroMedics Inc., Neuronetics Inc., NeuroPace Inc., Neuros Medical Inc., NeuroSigma Inc., NeuroVista Corp., Nevro Corp., and The Magstim Company Ltd.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.